{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "amyloid fibrils", "cannabidiol", "tau protein"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34944028", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "13"}], "Language": ["eng"], "ELocationID": ["3521", "10.3390/cells10123521"], "Journal": {"ISSN": "2073-4409", "JournalIssue": {"Volume": "10", "Issue": "12", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "13"}}, "Title": "Cells", "ISOAbbreviation": "Cells"}, "ArticleTitle": "Cannabidiol Inhibits Tau Aggregation In Vitro.", "Abstract": {"AbstractText": ["A hallmark of Alzheimer's disease (AD) is the accumulation of tau protein in the brain. Compelling evidence indicates that the presence of tau aggregates causes irreversible neuronal destruction, eventually leading to synaptic loss. So far, the inhibition of tau aggregation has been recognized as one of the most effective therapeutic strategies. Cannabidiol (CBD), a major component found in <i>Cannabis sativa</i> L., has antioxidant activities as well as numerous neuroprotective features. Therefore, we hypothesize that CBD may serve as a potent substance to hamper tau aggregation in AD. In this study, we aim to investigate the CBD effect on the aggregation of recombinant human tau protein 1N/4R isoform using biochemical methods in vitro and in silico. Using Thioflavin T (ThT) assay, circular dichroism (CD), and atomic force microscopy (AFM), we demonstrated that CBD can suppress tau fibrils formation. Moreover, by quenching assay, docking, and job's plot, we further demonstrated that one molecule of CBD interacts with one molecule of tau protein through a spontaneous binding. Experiments performed by quenching assay, docking, and Thioflavin T assay further established that the main forces are hydrogen Van der Waals and some non-negligible hydrophobic forces, affecting the lag phase of tau protein kinetics. Taken together, this study provides new insights about a natural substance, CBD, for tau therapy which may offer new hope for the treatment of AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614335, Iran."}], "LastName": "Alali", "ForeName": "Soha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614335, Iran."}], "LastName": "Riazi", "ForeName": "Gholamhossein", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614335, Iran."}], "LastName": "Ashrafi-Kooshk", "ForeName": "Mohammad Reza", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614335, Iran."}], "LastName": "Meknatkhah", "ForeName": "Sogol", "Initials": "S"}, {"Identifier": ["0000-0002-3436-465X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran 1417614335, Iran."}], "LastName": "Ahmadian", "ForeName": "Shahin", "Initials": "S"}, {"Identifier": ["0000-0002-0978-8303"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G.C., Evin, Tehran 1983969411, Iran."}], "LastName": "Hooshyari Ardakani", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Research Institute (BIOMED), Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium."}], "LastName": "Hosseinkhani", "ForeName": "Baharak", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cells", "NlmUniqueID": "101600052", "ISSNLinking": "2073-4409"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Benzothiazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Isoforms"}, {"RegistryNumber": "0", "NameOfSubstance": "tau Proteins"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}, {"RegistryNumber": "2390-54-7", "NameOfSubstance": "thioflavin T"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Benzothiazoles"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Brain"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cannabidiol"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Microscopy, Atomic Force"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neurons"}, {"QualifierName": ["drug therapy", "genetics", "pathology"], "DescriptorName": "Protein Aggregation, Pathological"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Protein Isoforms"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "ultrastructure"], "DescriptorName": "tau Proteins"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jicha: G.A., Carr S.A. Conceptual evolution in Alzheimer\u2019s disease: Implications for understanding the clinical phenotype of progressive neurodegenerative disease. J. Alzheimer\u2019s Dis. 2010;19:253\u2013272. doi: 10.3233/JAD-2010-1237.", "ArticleIdList": ["10.3233/JAD-2010-1237", "PMC2881218", "20061643"]}, {"Citation": "Pallo S.P., Johnson G.V. Tau facilitates A\u03b2-Induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons. Neurosci. Lett. 2015;597:32\u201337. doi: 10.1016/j.neulet.2015.04.021.", "ArticleIdList": ["10.1016/j.neulet.2015.04.021", "PMC4442715", "25888814"]}, {"Citation": "De Anda-Hern\u00e1ndez M.A., Lira-De Le\u00f3n K.I., Mena R., Campos-Pe\u00f1a V., Meraz-R\u00edos M.A. Neuroscience\u2013Dealing with Frontiers. IntechOpen; London, UK: 2012. Tau and Amyloid-\u03b2 Conformational Change to \u03b2-Sheet Structures as Effectors in the Development of Alzheimer\u2019s Disease; pp. 363\u2013388."}, {"Citation": "Papasozomenos S.C., Binder L.I. Phosphorylation determines two distinct species of Tau in the central nervous system. Cell Motil. Cytoskelet. 1987;8:210\u2013226. doi: 10.1002/cm.970080303.", "ArticleIdList": ["10.1002/cm.970080303", "2446784"]}, {"Citation": "Barghorn S., Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry. 2002;41:14885\u201314896. doi: 10.1021/bi026469j.", "ArticleIdList": ["10.1021/bi026469j", "12475237"]}, {"Citation": "Guo T., Noble W., Hanger D.P. Roles of tau protein in health and disease. Acta Neuropath. 2017;133:665\u2013704. doi: 10.1007/s00401-017-1707-9.", "ArticleIdList": ["10.1007/s00401-017-1707-9", "PMC5390006", "28386764"]}, {"Citation": "Karima O., Riazi G., Khodadadi S., Aryapour H., Khalili M.A., Yousefi L., Moosavi-Movahedi A.A. Altered tubulin assembly dynamics with N-Homocysteinylated human 4R/1N tau in vitro. FEBS Letters. 2012;586:3914\u20133919. doi: 10.1016/j.febslet.2012.09.024.", "ArticleIdList": ["10.1016/j.febslet.2012.09.024", "23041345"]}, {"Citation": "Ginsberg S.D., Che S., Counts S.E., Mufson E.J. Shift in the ratio of three-repeat tau and four-Repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease. J. Neurochem. 2006;96:1401\u20131408. doi: 10.1111/j.1471-4159.2005.03641.x.", "ArticleIdList": ["10.1111/j.1471-4159.2005.03641.x", "16478530"]}, {"Citation": "Kosik R.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally regulated expression of specific tau sequences. Neuron. 1989;2:1389\u20131397. doi: 10.1016/0896-6273(89)90077-9.", "ArticleIdList": ["10.1016/0896-6273(89)90077-9", "2560640"]}, {"Citation": "Mukrasch M.D., Bibow S., Korukottu J., Jeganathan S., Biernat J., Griesinger C., Mandelkow E., Zweckstetter M. Structural polymorphism of 441-Residue tau at single residue resolution. PLoS Biol. 2009;7:e1000034. doi: 10.1371/journal.pbio.1000034.", "ArticleIdList": ["10.1371/journal.pbio.1000034", "PMC2642882", "19226187"]}, {"Citation": "Deng Y., Jiao C., Mi C., Xu B., Li Y., Wang F., Liu W., Xu Z. Melatonin inhibits manganese-Induced motor dysfunction and neuronal loss in mice: Involvement of oxidative stress and dopaminergic neurodegeneration. Mol. Neurobiol. 2015;51:68\u201388. doi: 10.1007/s12035-014-8789-3.", "ArticleIdList": ["10.1007/s12035-014-8789-3", "24969583"]}, {"Citation": "Butterfield D.A., Boyd-Kimball D. Oxidative stress, amyloid-\u03b2 peptide and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2018;62:1345\u20131367. doi: 10.3233/JAD-170543.", "ArticleIdList": ["10.3233/JAD-170543", "PMC5870019", "29562527"]}, {"Citation": "Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer\u2019s disease. Brain Pathol. 1999;9:133\u2013146. doi: 10.1111/j.1750-3639.1999.tb00215.x.", "ArticleIdList": ["10.1111/j.1750-3639.1999.tb00215.x", "PMC8098393", "9989456"]}, {"Citation": "Esteras N., Kundel F., Amodeo G.F., Pavlov E.V., Klenerman D., Abramov A.Y. Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-Gated calcium channels and NADPH oxidase. FEBS J. 2021;288:127\u2013141. doi: 10.1111/febs.15340.", "ArticleIdList": ["10.1111/febs.15340", "32338825"]}, {"Citation": "Pitchumoni S.S., Doraiswamy P.M. Current status of antioxidant therapy for Alzheimer\u2019s disease. J. Am. Geriatr. Society. 1998;46:1566\u20131572. doi: 10.1111/j.1532-5415.1998.tb01544.x.", "ArticleIdList": ["10.1111/j.1532-5415.1998.tb01544.x", "9848820"]}, {"Citation": "Atalay S., Jarocka-Karpowicz I., Skrzydlewska E. Antioxidative and anti-Inflammatory properties of cannabidiol. Antioxidants. 2020;9:21. doi: 10.3390/antiox9010021.", "ArticleIdList": ["10.3390/antiox9010021", "PMC7023045", "31881765"]}, {"Citation": "Borges R.S., Batista J., Viana R.B., Baetas A.C., Orestes E., Andrade M.A., Hon\u00f3rio K.M., Da Silva A.B. Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants. Molecules. 2013;18:12663\u201312674. doi: 10.3390/molecules181012663.", "ArticleIdList": ["10.3390/molecules181012663", "PMC6269679", "24129275"]}, {"Citation": "Vall\u00e9e A., Lecarpentier Y., Guillevin R., Vall\u00e9e J.N. Effects of cannabidiol interactions with Wnt/\u03b2-Catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer\u2019s disease. Acta Biochim. Biophys. Sinica. 2017;49:853\u2013866. doi: 10.1093/abbs/gmx073.", "ArticleIdList": ["10.1093/abbs/gmx073", "28981597"]}, {"Citation": "Scuderi C., Steardo L., Esposito G. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement. Phytother. Res. 2014;28:1007\u20131013. doi: 10.1002/ptr.5095.", "ArticleIdList": ["10.1002/ptr.5095", "24288245"]}, {"Citation": "Ali Nasiri Khalili M., Riazi G., Ahmadian S., Khodarahmi R., Khodadadi S., Afrasiabi A., Karima O., Mokhtari F., Hoveizi E. The role of anionic peptide fragments in 1N4R human tau protein aggregation. Protein Pept. Letters. 2014;21:511\u2013516. doi: 10.2174/0929866521666131223120713.", "ArticleIdList": ["10.2174/0929866521666131223120713", "24364857"]}, {"Citation": "Jangholi A., Ashrafi-Kooshk M.R., Arab S.S., Riazi G., Mokhtari F., Poorebrahim M., Mahdiuni H., Kurganov B.I., Moosavi-Movahedi A.A., Khodarahmi R. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-Residue 1N4R Tau protein: A comparative study. Arch. Biochem. Biophy. 2016;609:1\u20139. doi: 10.1016/j.abb.2016.09.004.", "ArticleIdList": ["10.1016/j.abb.2016.09.004", "27638048"]}, {"Citation": "Karakani A.M., Riazi G., Ghaffari S.M., Ahmadian S., Mokhtari F., Firuzi M.J., Bathaie S.Z. Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro. Iran. J. Basic Med. Sci. 2015;18:485.", "ArticleIdList": ["PMC4475657", "26124935"]}, {"Citation": "Ghasemzadeh S., Riazi G.H. Inhibition of Tau amyloid fibril formation by folic acid: In-Vitro and theoretical studies. Int. J. Biol. Macromolecules. 2020;154:1505\u20131516. doi: 10.1016/j.ijbiomac.2019.11.032.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.032", "31751728"]}, {"Citation": "Ramachandran G., Udgaonkar J.B. Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau. J. Mol. Biol. 2012;421:296\u2013314. doi: 10.1016/j.jmb.2012.01.007.", "ArticleIdList": ["10.1016/j.jmb.2012.01.007", "22281439"]}, {"Citation": "Divsalar A., Saboury A.A., Yousefi R., Moosavi-Movahedi A.A., Mansoori-Torshizi H. Spectroscopic and cytotoxic studies of the novel designed palladium (II) complexes: \u03b2-Lactoglobulin and K562 as the targets. Int. J. Biol. Macromol. 2007;40:381\u2013386. doi: 10.1016/j.ijbiomac.2006.09.015.", "ArticleIdList": ["10.1016/j.ijbiomac.2006.09.015", "17097727"]}, {"Citation": "Hu Y.J., Yue H.L., Li X.L., Zhang S.S., Tang E., Zhang L.P. Molecular spectroscopic studies on the interaction of morin with bovine serum albumin. J. Photochem. Photobiol. B Biol. 2012;112:16\u201322. doi: 10.1016/j.jphotobiol.2012.04.001.", "ArticleIdList": ["10.1016/j.jphotobiol.2012.04.001", "22564497"]}, {"Citation": "Sonu V.K., Rajkumar I., Bhattacharjee K., Joshi S.R., Mitra S. Interaction of caffeine and sulfadiazine with lysozyme adsorbed at colloidal metal nanoparticle interface: Influence on drug transport ability and antibacterial activity. J. Biomol. Struct. Dyn. 2019;37:321\u2013335. doi: 10.1080/07391102.2018.1426497.", "ArticleIdList": ["10.1080/07391102.2018.1426497", "29320928"]}, {"Citation": "Lakowicz J.R., editor. Principles of Fluorescence Spectroscopy. Springer Science & Business Media; Berlin/Heildberg, Germany: 2013."}, {"Citation": "Jayabharathi J., Thanikachalam V., Srinivasan N., Perumal M.V. Luminescent study on the binding interaction of bioactive imidazole with bovine serum albumin\u2014A static quenching mechanism. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;84:233\u2013237. doi: 10.1016/j.saa.2011.09.033.", "ArticleIdList": ["10.1016/j.saa.2011.09.033", "21993253"]}, {"Citation": "Sun Y., Wei S., Yin C., Liu L., Hu C., Zhao Y., Ye Y., Hu X., Fan J. Synthesis and spectroscopic characterization of 4-Butoxyethoxy-N-Octadecyl-1, 8-Naphthalimide as a new fluorescent probe for the determination of proteins. Bioorg. Med. Chem. Lett. 2011;21:3798\u20133804. doi: 10.1016/j.bmcl.2011.04.026.", "ArticleIdList": ["10.1016/j.bmcl.2011.04.026", "21561769"]}, {"Citation": "Rahman M.H., Maruyama T., Okada T., Yamasaki K., Otagiri M. Study of interaction of carprofen and its enantiomers with human serum albumin\u2014I: Mechanism of binding studied by dialysis and spectroscopic methods. Biochem. Pharmacol. 1993;46:1721\u20131731. doi: 10.1016/0006-2952(93)90576-I.", "ArticleIdList": ["10.1016/0006-2952(93)90576-I", "7504487"]}, {"Citation": "Job P. Formation and stability of inorganic complexes in solution. Ann. chim. 1928;9:113."}, {"Citation": "Ingham K.C. On the application of Job\u2019s method of continuous variation to the stoichiometry of protein-Ligand complexes. Anal. Biochem. 1975;68:660\u2013663. doi: 10.1016/0003-2697(75)90666-1.", "ArticleIdList": ["10.1016/0003-2697(75)90666-1", "1200365"]}, {"Citation": "Achilles Blind Docking Server.  [(accessed on 28 September 2021)].  Available online:  https://bio-hpc.ucam.edu/achilles/"}, {"Citation": "Pymol.  [(accessed on 28 September 2021)].  Available online:  https://pymol.org/2/"}, {"Citation": "Ross P.D., Subramanian S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry. 1981;20:3096\u20133102. doi: 10.1021/bi00514a017.", "ArticleIdList": ["10.1021/bi00514a017", "7248271"]}, {"Citation": "Shahabadi N., Kashanian S., Darabi F. In vitro study of DNA interaction with a water-Soluble dinitrogen Schiff base. DNA Cell Biol. 2009;28:589\u2013596. doi: 10.1089/dna.2009.0881.", "ArticleIdList": ["10.1089/dna.2009.0881", "19732014"]}, {"Citation": "Jeffrey G.A., Jeffrey G.A. An Introduction to Hydrogen Bonding. Oxford University Press; New York, NY, USA: 1997."}, {"Citation": "Demaegd K., Schymkowitz J., Rousseau F. Transcellular spreading of tau in tauopathies. Chem. Biochem. 2018;19:2424. doi: 10.1002/cbic.201800288.", "ArticleIdList": ["10.1002/cbic.201800288", "PMC6391987", "30133080"]}, {"Citation": "Wischik C.M., Edwards P.C., Lai R.Y., Roth M., Harrington C.R. Selective inhibition of Alzheimer disease-Like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. USA. 1996;93:11213\u201311218. doi: 10.1073/pnas.93.20.11213.", "ArticleIdList": ["10.1073/pnas.93.20.11213", "PMC38310", "8855335"]}, {"Citation": "Nieva R., Safavynia S.A., Bishop K.L., Sperling L. Herbal, vitamin and mineral supplement use in patients enrolled in a cardiac rehabilitation program. J. Cardiopulm. Rehabil. Prev. 2012;32:270. doi: 10.1097/HCR.0b013e31825f78f0.", "ArticleIdList": ["10.1097/HCR.0b013e31825f78f0", "PMC4317371", "22878561"]}, {"Citation": "Patwa H.S. Commentaries on the Current Treatment of Selected Neurologic Diseases. Clin. Therap. 2013;35:1478\u20131479. doi: 10.1016/j.clinthera.2013.09.007.", "ArticleIdList": ["10.1016/j.clinthera.2013.09.007", "24139419"]}, {"Citation": "Rahmani S., Mogharizadeh L., Attar F., Rezayat S.M., Mousavi S.E., Falahati M. Probing the interaction of silver nanoparticles with tau protein and neuroblastoma cell line as nervous system models. J. Biomol. Struct. Dynam. 2018;36:4057\u20134071. doi: 10.1080/07391102.2017.1407673.", "ArticleIdList": ["10.1080/07391102.2017.1407673", "29173031"]}, {"Citation": "Carlson S.W., Branden M., Voss K., Sun Q., Rankin C.A., Gamblin T.C. A complex mechanism for inducer mediated tau polymerization. Biochemistry. 2007;46:8838\u20138849. doi: 10.1021/bi700403a.", "ArticleIdList": ["10.1021/bi700403a", "17608454"]}, {"Citation": "Von Bergen M., Barghorn S., M\u00fcller S.A., Pickhardt M., Biernat J., Mandelkow E.M., Davies P., Aebi U., Mandelkow E. The core of tau-Paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry. 2006;45:6446\u20136457. doi: 10.1021/bi052530j.", "ArticleIdList": ["10.1021/bi052530j", "16700555"]}, {"Citation": "Seidler P.M., Boyer D.R., Rodriguez J.A., Sawaya M.R., Cascio D., Murray K., Gonen T., Eisenberg D.S. Structure-Based inhibitors of tau aggregation. Nat. Chem. 2018;10:170\u2013176. doi: 10.1038/nchem.2889.", "ArticleIdList": ["10.1038/nchem.2889", "PMC5784779", "29359764"]}, {"Citation": "Nishiura C., Takeuchi K., Minoura K., Sumida M., Taniguchi T., Tomoo K., Ishida T. Importance of Tyr310 residue in the third repeat of microtubule binding domain for filament formation of tau protein. J. Biochem. 2010;147:405\u2013414. doi: 10.1093/jb/mvp181.", "ArticleIdList": ["10.1093/jb/mvp181", "19897570"]}, {"Citation": "Shi Z., Ford J.V., Wei S., Castleman Jr A.W. Water clusters: Contributions of binding energy and entropy to stability. J. Chem. Phys. 1993;99:8009\u20138015. doi: 10.1063/1.465678.", "ArticleIdList": ["10.1063/1.465678"]}, {"Citation": "Sibille N., Sillen A., Leroy A., Wieruszeski J.M., Mulloy B., Landrieu I., Lippens G. Structural impact of heparin binding to full-Length Tau as studied by NMR spectroscopy. Biochemistry. 2006;45:12560\u201312572. doi: 10.1021/bi060964o.", "ArticleIdList": ["10.1021/bi060964o", "17029411"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "30"}, {"Year": "2021", "Month": "12", "Day": "3"}, {"Year": "2021", "Month": "12", "Day": "9"}, {"Year": "2021", "Month": "12", "Day": "24", "Hour": "1", "Minute": "4"}, {"Year": "2021", "Month": "12", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["34944028", "PMC8700709", "10.3390/cells10123521", "cells10123521"]}}], "PubmedBookArticle": []}